Gil Blum

Stock Analyst at Needham

(2.06)
# 2,855
Out of 4,883 analysts
393
Total ratings
35.47%
Success rate
-5.85%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Gil Blum

Taysha Gene Therapies
Jul 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.34
Upside: +241.88%
Celcuity
Jun 30, 2025
Reiterates: Buy
Price Target: $29
Current: $12.49
Upside: +132.19%
CRISPR Therapeutics AG
Jun 26, 2025
Reiterates: Buy
Price Target: $81
Current: $48.51
Upside: +66.98%
Autolus Therapeutics
Jun 12, 2025
Reiterates: Buy
Price Target: $10
Current: $2.29
Upside: +336.68%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23$18
Current: $1.53
Upside: +1,076.47%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.59
Upside: +247.49%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $64.78
Upside: +62.10%
I-Mab
Jun 27, 2025
Maintains: Buy
Price Target: $4$5
Current: $2.34
Upside: +113.68%
Sarepta Therapeutics
Jun 16, 2025
Maintains: Buy
Price Target: $125$50
Current: $17.71
Upside: +182.33%
Fate Therapeutics
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.14
Upside: -
Downgrades: Hold
Price Target: $42
Current: $2.59
Upside: +1,521.62%
Maintains: Buy
Price Target: $11$10
Current: $1.71
Upside: +484.80%
Reiterates: Buy
Price Target: $7
Current: $2.76
Upside: +153.62%
Maintains: Buy
Price Target: $41$40
Current: $11.01
Upside: +263.31%
Reiterates: Buy
Price Target: $8
Current: $0.32
Upside: +2,400.00%
Maintains: Buy
Price Target: $11$8
Current: $5.13
Upside: +55.95%
Reiterates: Buy
Price Target: $27
Current: $11.71
Upside: +130.57%
Reiterates: Buy
Price Target: $71
Current: $32.84
Upside: +116.20%
Reiterates: Buy
Price Target: $9
Current: $1.43
Upside: +529.37%
Reiterates: Hold
Price Target: n/a
Current: $0.82
Upside: -
Reiterates: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Reiterates: Hold
Price Target: n/a
Current: $5.84
Upside: -
Reiterates: Buy
Price Target: $4
Current: $0.44
Upside: +817.43%